Molgramostim Open-label

Drug identity checked against registry records

Also recorded as Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF)

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)NCT04544293SVRAPhase 3Active not recruiting2023-11-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.